BCN HEALTH publishes a study highlighting the substantial healthcare costs associated with... 03/06/2025 Healthcare Access to innovation BCN HEALTH has published the study ‘Hepatocellular carcinoma: what are the differential costs compared to the general... Partners - BCN Health
Accelerating molecular discovery using an in silico design platform 08/07/2025 Healthcare Access to innovation Drug discovery Innovative drugs Advanced therapies Industrial biotechnology Join our free event on Tuesday, July 8th at the Parque Científico de Barcelona for an extended version of our Lunch and... Partners
#NewAseBioMember | “#NewAseBioMember | “AseBio is the meeting point for all companies that... 02/06/2025 Healthcare Corporate Meet our new member Microviable Therapeutics . We sponke with Claudio Hidalgo Cantabrana, CEO. AseBio - MICROVIABLE THERAPEUTICS
BioDuro hosts webinar: "Exploring Peptide In-Vitro ADME Properties – From Natural Peptides... 30/05/2025 Healthcare Drug discovery Innovative drugs Advanced therapies The webinar exploring the in-vitro ADME (Absorption, Distribution, Metabolism, and Excretion) properties of peptide... Partners - BIODURO
University of Barcelona Science Park ecosystem holds steady with €124 million in investmen... 28/05/2025 Healthcare Industrial biotechnology Talento The 86 spin-offs, start-ups and scale-ups operating in the PCB collectively secured €124.7 million in funding in 2024... Partners - Parc Científic de Barcelona
World Multiple Sclerosis Day | “The integration of biotechnology and AI allows us to move ... 30/05/2025 Healthcare Personalized medicine Advanced therapies Interview with Mireia Forner, Medical Head of Neurology at Sanofi Iberia, a company working to change how multiple... AseBio - SANOFI
World Multiple Sclerosis Day | “The integration of biotechnology and AI allows us to move ... 30/05/2025 SANOFI Interview with Mireia Forner, Medical Head of Neurology at Sanofi Iberia, a company working to change how multiple... AseBio - SANOFI
Detecting the Undetectable: How Altum Sequencing Is Transforming Acute Myeloid Leukemia Mo... 29/05/2025 Healthcare Personalized medicine We demonstrated that our assay could detect residual disease in AML patients after treatment with 92% sensitivity and 88... Partners - Altum Sequencing
Accelerating molecular discovery using an in silico design platform 29/05/2025 Healthcare Schrödinger will host a scientific workshop in Barcelona on July 8 to showcase how its molecular design platform... Partners
Bioga and five Galician biotech companies to attend Swiss Biotech Day 2025 to network and ... 28/05/2025 Healthcare International Bioga and five Galician biotech companies joined Swiss Biotech Day 2025, one of Europe’s leading life sciences events... Partners - BIOGA
